Právní předpis byl sestaven k datu 01.05.2017.
Zobrazené znění právního předpisu je účinné od 01.05.2017 do 07.03.2018.
Příloha č. 1 - Seznam č. 1 omamných látek
Příloha č. 2 - Seznam č. 2 omamných látek
Příloha č. 3 - Seznam č. 3 omamných látek
Příloha č. 4 - Seznam č. 4 psychotropních látek
Příloha č. 5 - Seznam č. 5 psychotropních látek
Příloha č. 6 - Seznam č. 6 psychotropních látek
Příloha č. 7 - Seznam č. 7 psychotropních látek
Příloha č. 8 - Seznam č. 8 vybraných přípravků
č. 46/2017 Sb. - Čl. II
463
XXXXXXXX XXXXX
xx xxx 18. xxxxxxxx 2013
x xxxxxxxxx návykových xxxxx
Xxxxx xxxxxxxx podle §44c xxxx. 1 xxxxxx x. 167/1998 Xx., x návykových xxxxxxx x x xxxxx xxxxxxxxx xxxxxxx xxxxxx, xx znění xxxxxx x. 273/2013 Sb.:
§1
Toto xxxxxxxx stanoví
a) x příloze č. 1 k xxxxxx nařízení xxxxxx
1. xxxxxxxx látek xxxxxxxxxx xx Xxxxxxx X xxxxx Xxxxxxxx xxxxxx x xxxxxxxx xxxxxxx1) x
2. xxxxxxx xxxxxxxx xxxxx, s nimiž xx x důvodu xxxxxxx xxxxxx xxxxxxxxxx xxxxx xxxxx, xx xxxxxxxxxxxxx nebo nepřímo xxxxxxxx xxxxxx, nezbytné xxxxxxx xxxxxxxxx jen xx základě xxxxxxxx x xxxxxxxxx, xxxx xx x tohoto xxxxxx xxxxx zabezpečit, xxx xxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxx xxxxx xxxx xxxxxxxx x xxxxxxx xxxxx xx xxxxxx nebo xxxxxxx označené xxxxxx xxxxxx xxxxxxxxxx x xxxxxx xxxxxxx xxxx xx xxxxxxx horního xxxx,
(xxxx jen "xxxxxx x. 1 omamných xxxxx"),
x) v příloze č. 2 x tomuto nařízení xxxxxx
1. omamných xxxxx xxxxxxxxxx xx Xxxxxxx XX podle Xxxxxxxx xxxxxx x xxxxxxxx xxxxxxx x
2. xxxxxxx xxxxxxxx xxxxx, u xxxxx xx x xxxxxx rozsahu xxxxxx xxxxxxxxxx xxxxx proto, xx xxxxxxxxxxxxx xxxx xxxxxxx ohrožují xxxxxx, xxxxx zabezpečit, xxx xxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxx látky xxxx xxxxxxxx x xxxxxxx na xxxxxx xxxx xxxxxxx xxx xxxxxxxx xxxxxx xxxxxx,
(xxxx xxx "xxxxxx x. 2 xxxxxxxx xxxxx"),
x) x příloze č. 3 x xxxxxx xxxxxxxx xxxxxx
1. xxxxxxxx xxxxx zařazených xx Xxxxxxx IV xxxxx Xxxxxxxx xxxxxx x xxxxxxxx látkách x
2. xxxxxxx xxxxxxxx xxxxx, u xxxxx xx x xxxxxx xxxxxxx xxxxxx zneužívání xxxxx xxxxx, xx xxxxxxxxxxxxx nebo nepřímo xxxxxxxx xxxxxx, xxxxx xxxxxxxxxx, aby xxxxx x xxxxxxxxx obsahující xxxx xxxxxx xxxxx xxxx xxxxxxxxx pouze x xxxxxxxx výzkumným, xxxxxxxx x xxxxx xxxxxxxx terapeutickým xxxxxx xxxxxxxxx x xxxxxxxx x zacházení,
(dále xxx "xxxxxx x. 3 xxxxxxxx xxxxx"),
x) v příloze č. 4 k xxxxxx xxxxxxxx xxxxxx
1. psychotropních xxxxx zařazených xx Xxxxxxx X xxxxx Xxxxxx x psychotropních xxxxxxx2) a
2. dalších xxxxxxxxxxxxxx xxxxx, x xxxxx xx x xxxxxx rozsahu xxxxxx xxxxxxxxxx xxxxx xxxxx, xx bezprostředně nebo xxxxxxx xxxxxxxx xxxxxx, xxxxx xxxxxxxxxx, aby xxxxx a xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxxxxx xxxxx xxxx xxxxxxxxx xxxxx k xxxxxxxx xxxxxxxxx, vědeckým a xxxxx xxxxxxxx terapeutickým xxxxxx xxxxxxxxx v xxxxxxxx k zacházení,
(dále xxx "xxxxxx x. 4 xxxxxxxxxxxxxx xxxxx"),
x) x příloze č. 5 x xxxxxx nařízení xxxxxx
1. xxxxxxxxxxxxxx xxxxx xxxxxxxxxx xx Seznamu II xxxxx Úmluvy x xxxxxxxxxxxxxx látkách x
2. xxxxxxx xxxxxxxxxxxxxx xxxxx, x nimiž xx x xxxxxx xxxxxxx xxxxxx xxxxxxxxxx anebo xxxxx, xx bezprostředně xxxx xxxxxxx xxxxxxxx xxxxxx, xxxxxxxx umožnit xxxxxxxxx xxx xx xxxxxxx povolení x xxxxxxxxx, xxxx xx x xxxxxx xxxxxx xxxxx zabezpečit, xxx xxxxxx xxxxxxxxx obsahující xxxx xxxxxxxxxxxx xxxxx xxxx xxxxxxxx x xxxxxxx xxxxx na xxxxxx xxxx xxxxxxx xxxxxxxx modrým xxxxxx xxxxxxxxxx x xxxxxx xxxxxxx rohu xx xxxxxxx xxxxxxx xxxx,
(xxxx xxx "xxxxxx x. 5 xxxxxxxxxxxxxx xxxxx"),
x) x příloze č. 6 x xxxxxx xxxxxxxx xxxxxx xxxxxxxxxxxxxx látek xxxxxxxxxx xx Xxxxxxx XXX xxxxx Xxxxxx o xxxxxxxxxxxxxx látkách,
x) v příloze č. 7 k xxxxxx xxxxxxxx seznam
1. psychotropních xxxxx xxxxxxxxxx do Xxxxxxx XX xxxxx Xxxxxx x xxxxxxxxxxxxxx xxxxxxx a
2. dalších xxxxxxxxxxxxxx xxxxx, u xxxxx je z xxxxxx xxxxxxx jejich xxxxxxxxxx xxxxx xxxxx, xx bezprostředně xxxx xxxxxxx xxxxxxxx xxxxxx, xxxxx xxxxxxxxxx, aby xxxxxx xxxxxxxxx xxxxxxxxxx xxxx látky byly xxxxxxxx x xxxxxxx xx xxxxxx xxxx xxxxxxx xxx označení xxxxxx xxxxxx,
(xxxx xxx "xxxxxx č. 7 xxxxxxxxxxxxxx xxxxx"), a
h) x příloze č. 8 x xxxxxx xxxxxxxx xxxxxx xxxxxxxxx xxxxxxxxxx xx Xxxxxxx XXX xxxxx Xxxxxxxx xxxxxx x xxxxxxxx xxxxxxx,
(xxxx xxx "xxxxxx č. 8 xxxxxxxxx přípravků").
§2
Toto xxxxxxxx bylo xxxxxxxx v xxxxxxx xx směrnicí Xxxxxxxxxx xxxxxxxxxx a Xxxx 98/34/ES xx xxx 22. xxxxxx 1998 x postupu xxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx norem x xxxxxxxxxxx předpisů x xxxxxxxx xxx xxxxxx xxxxxxxxxx společnosti, v xxxxxxx znění.
§3
Toto nařízení xxxxxx xxxxxxxxx xxxx 1. xxxxx 2014.
Xxxxxxx x. 1 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 1 xxxxxxxx xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x xxxxxx xxxxxx |
Xxxxxxxx název podle XXXXX |
Xxxxxxxx |
|
Xxxxxxxxx |
(5X,6X,7X)-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx-17-xxxxxx-4,5-xxxxx- 6,14-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
|
XxxxxX-xxxx-xxxxxxxxxxxxxx |
(XX)-X-[1-(2-xxxxX-2-xxxxxxxxxxx)-4-xxxxxxxxx]xxxxxxxxxx |
|
|
XxxxxXxxxxxxxx |
(3XX)-6-(xxxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
|
Xxxxxxxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
|
Xxxxxxxxxxxx |
(3XX,4Xx)-3-xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxx-xxxxxxxxxxxxxx |
X-{1-[(1XX)-2-xxxxx-1-xxxxxxxxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxx-xxxxxxxxxxxxxxxxxx |
X-{1-[(1XX)-1-xxxxxx-2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
XXxxxxxxxx |
(3X,4XX)-4-xxxxx-1,3-xxxxxxxxxxxxxxxxx-4-xX-xxxxxxxxx |
|
|
Xxxxxxxxxx |
X-{1-[2-(4-xxxxx-5-xxx-4,5-xxxxxxx-1X-xxxxxxxx-1-xx)xxxxx]-4-(xxxxxxxxxxxxx) piperidin-4-yl}-N-fenylpropanamid |
|
|
Allylprodin |
3-allyl-4-fenyl-1-methylpiperidin-4-yl-propanoát |
|
|
Anileridin |
elhyl-1-(4-aminofenethyl)-4-fenylpiperidin-4-karboxylát |
|
|
Benzethidin |
ethyl-1-[2-(benzyloxy)ethyl]-4-fenylpiperidin-4-karboxylát |
|
|
Benzylmorfin |
3-(bertzyIoxy)-4.5α-epoxy-17-methylmorfin-7-en-6α-ol |
|
|
Betacethylmethadol |
(3S,6R)-6-{dimethylameno )-4.4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
|
Xxxx-xxxxxxxxxxxxxxx |
X-{1-[(2XX)-2-xxxxxxxxxxxxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxx-xxxxxxxxxxxxxxxxxxxxx |
X-{1-[(2XX)-2-xxxxxxxxxxxxxxx]-3-xxxxxxxxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxxxxxxxxxx |
(3XX,4XX)-3-xxxxx-4-xxxxX-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxx |
(3XX,4XX)-4-xxxxx-1,3-xxxxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxx |
2,2-xxxxxxX-4-[4-(2-xxx-3-xxxxxxxxX-2,3-xxxxxxx-1X-xxxxxxxxxxxx-1-xx) xxxxxxxxxx]xxxxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
1-[(3X)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxxxxxxxxxx]xxxxxxxxxx |
|
|
Xxxxxxxxxx |
X-[2-(X-xxxxxxxx-X-xxxxxxxxxxx)xxxxxx]xxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxx |
3-(xxxxxxxxxxxx)-1,1-xx(2-xxxxxxx)xxx-1-xx |
|
|
Xxxxxxxxx |
1-(3,3-xxxxxxx-3-xxxxxxxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxxx xxxxxxxx |
|
|
Xxxxxxxxxxx |
xxxxx-1-(3,3-xxxxxxx-3-xxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
(5X,6X,7X)-4,5-xxxxx-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx-17-xxxxxx- 6,14-xxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3,6α-xxxx |
|
|
Xxxxxxxxxxx |
[2-(xxxxxxxxxxxxx)xxxxx)]-2-xxxxxx-2,2-xxxxxxx-xxxxxx |
|
|
Xxxxxxxxxxxx |
6-(xxxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxxxxxxxxx |
X,X,1-xxxxxxxxx-3,3-xx(2-xxxxxxx)xxxxxxxxx |
|
|
Xxxxxxxxxx-xxxxxxx |
xxxxx-2,2-xxxxxxx-4-xxxxxxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
|
Xxxxxxxxx |
(6XX)-4,4-xxxxxxx-6-xxxxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxx |
(6X)-3,4-xxxxxxxxx-17-xxxxxxxxxxxxxx-6β,14-xxxx |
|
|
Xxxxxxx |
xxxxxxxx (1R,2R,3S,5S)-3-hydroxy-8-methyl-9-azabicyklo[3.2.1]oktan-2-karboxylová, xxxx xxxxxx a xxxxxxxx, x xxxxxxx xx xxxxx xxxxxx xxxxxxx x xxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxx |
X-xxxxx-X,1-xxxxxxxx-3,3-xxx(2-xxxxxxx)-2-xxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
1-[2-(xxxxxxxxxxxx)xxxxx]-2-(4-xxxxxxxxxxxx]-5-xxxxx-1X-xxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxx-4-xxxxx-1-[2-(2-xxxxxxxxxxxxx)xxxxx]xxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxx |
4,4-xxxxxxx-6-xxxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxx |
X-(1-xxxxxx-2-xxxxxxxxxxxxxxx)xxxxxxxxxxxx |
|
|
Xxxxxxxxx |
(2XX,6X,11X)-3-xxxxxxxx-6,11-xxxxxxxx-1,2,3,4,5,6-xxxxxxxxx-2,6-xxxxxxx- 3-benzazocin-8-ol |
|
|
Fenomorfan |
17-fenethyImorfinan-3-ol |
|
|
Fenoperidin |
ethyl-4-fenyl-1-(3-fenylpropyl)-3-hydroxypiperidin-4-karboxylát |
|
|
Fentanyl |
N-(1-fenethylpiperidin-4-yl)-N-fenylpropanamid |
|
|
Furethidin |
ethyI-4-fenyI-1-[2-(furfuryloxy)ethyl]piperidinn-4-karboxylát |
|
|
Hydrokodon |
4,5α-epoxy-3-methoxy-17-rnethyImorfinan-6-on |
|
|
Hydromorfinol |
4,5α-epoxy-17-methylmorfinan-3,6α,14-triol |
|
|
Hydromorfon |
4,5α-epoxy-3-hydroxy-17-rnethylmorfinan-6-on |
|
|
Hydroxypethidin |
ethyl-4-(3-hydroxyfenyl)-1-rnethylpiperidin-4-karboxylát |
|
|
lsomethadon |
6-(dimethylamino)-4,4-difenyl-5-methylhexan-3-on |
|
|
Karfentanil |
methyl-1-fenethyl-4-(N-fenylpropanamido)piperidin-4-karboxylát |
|
|
Klonitazen |
2-(4-chlorbenzyl)-1-[2-(diethylarnino)ethyl]-5-nitro-1H-benzimidazol |
|
|
Kodoxim |
kyselina 2-{[X-(4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxxx-6-xxxxxx) xxxxx]xxx}xxxxxx |
|
|
Xxxx - xxxx |
Xxxxxx xxxx |
|
|
Xxxxxx |
(1X,2X,3X,5X)-3-(xxxxxxxxxx)-8-xxxxxx-8-xxxxxxxxxx[3.2.1]xxxxx-2- karboxylát |
|
|
Koncentrát x xxxxxxxx |
Xxxxxxxxxxx k xxxxxx xxxxxxxxx získaný xxxxxxxxxxxxxx úpravou xxxxxxxx |
|
|
Xxxxxx xxxxxxx a xxxxxxxx |
Xxxxxxx x xxxxxxxx z xxxxxx |
|
|
Xxxxxx xxx xxxxxxx xxxxxxx |
xxxxxx xxxxxx x xxxxxxxx xxxxxxxx přípravků xx standardizovaným xxxxxxx xxxxxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxx |
1-xxxxx-2-[(9X,13X,14X)3-xxxxxxxxxxxxxxx-17-xx]xxxxx-1-xx |
|
|
Xxxxxxxxxxxxx |
(9X,13X,14X)-3-xxxxxxxx-17-xxxxxxxxxxxxxx |
Xxxxxxxxxxxxxx xxxxxxxxxxxxxxx [(+)-3-xxxxxxx-17- xxxxxxxxxxxxxx] xx vyňat xx xxxxxxx xxxxxxxx xxxxx uvedených x xxxx xxxxxxx |
|
Xxxxxxxxxxx |
(3X)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxx-1-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
|
Xxxxxxxxxx |
(9X,13X,14X)-17-xxxxxxxxxxxxxx-3-xx |
Xxxxxxxxxxxxxx dextrofanol [(+)-3-xxxxxxx-17- xxxxxxxxxxxxxx] xx xxxxx ze xxxxxxx xxxxxxxx xxxxx uvedených x této xxxxxxx |
|
Xxxxxxxxx |
(2X,6X,11X)-3,6,11-xxxxxxxxx-1,2,3,4,5,6-xxxxxxxxx-2,6-xxxxxxxxx-3- xxxxxxxxx-8-xx |
|
|
Xxxxxxxx |
(6XX)-6-(xxxxxxxxxxxxx)4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxx, xxxxxxxxxxx |
4-(xxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
4,5α-xxxxx-6,17-xxxxxxxxxxxxxx-6-xx-3-xx |
|
|
Xxxxxxxxxxxxxxxxxxx |
4,5-xxxxx-6,17-xxxxxxxxxxxxxxxx-3,6-xxxx |
|
|
Xxxxxxx |
4,5-xxxxx-3-xxxxxxx-5,17-xxxxxxxxxxxxxxxx-6-xx |
|
|
Xxxxxxx, meziprodukt |
2,2-difenyl-3-methyl-4-rnorfolinobutanová xxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
X-(1-xxxxxxxx-3-xxxxxxxxxxxxxxx-4-xx)xxxxxxxxxxxx |
3-Xxxxxxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxx |
X-{(3XX)-3-xxxxxx-1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
3-xxxxxxxxxxxxxxxxxx |
|
Xxxxxxxxxx |
xxxxx-4-xxxxx-1-(3-xxxxxxxxxxxxxx)xxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxx |
4,5α-xxxxx-17-xxxxxXxxxxxx-7-xx-3,6α-xxxx |
|
|
Xxxxxx xxxxxxxxxxx |
4,5α-xxxxx-3,6α-xxxxxxxxx-17,17-xxxxxxxxxxxxxx-7-xx-17-xxx-xxxxxx |
x xxxx xxxxxxxx xxxxxxx xx xxxxxxxxxx xxxxxxx včetně xxxxxxxx morfin-N-oxidu (x xxxxxx-X-xxxxx) |
|
Xxxxxx-X-xxxx |
4,5α -xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx-17-xxxx |
|
|
XxxxxxxxXxxxxxx |
4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
XXXX |
|
Xxxxxxx |
3-(xxxxxxxxx)-4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-6-xx-xxxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx-xxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
4,4-xxxxxxx-6-(xxxxxxxxxxx)xxxxxx-3-xx-xxxxxx |
|
|
Xxxxxxxxxxxxx |
(9X,13X,14X)-xxxxxxxx-3-xx |
|
|
Xxxxxxxxxxx |
6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxx |
4,5α-xxxxxxxxxxx-7-xx-3,6α-xxxX |
|
|
Xxxxxxxxxx |
4,4-xxxxxxx-6-xxxxxxxxxxxxxxx-3-xx |
|
|
Xxxxx |
Xxxxx xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx, xxxxxxx xxxxxx ředění xx xxxxx xxx X4 xxxx CH2 |
|
|
Oripavin |
4,5α-epoxy-6-methoxy-17-methylmorfina-6,8(14)-dien-3-ol |
|
|
Oxykodon |
(5R)-4,5-epoxy-14-hydroxy-3-methoxy-17-methylmorfinan-6-on |
|
|
Oxymorfon |
(5R)-4,5-epoxy-3,14-dihydroxy-17-methylmorfinan-6-on |
|
|
Parafluorfentanyl |
N-(1-fenethyIpiperidin-4-yl)-4'-fluorpropanamilid |
|
|
Pheneridin |
ethyl-1-fenethyl-4-fenylpiperidin-4-karboxylát |
PEPAP |
|
Pethidin |
ethyl-4-fenyl-1-methylpiperidin-4-karboxylát |
|
|
Pethidin, xxxxxxxxxxx X |
4-xxxxx-1-xxxxxxxxxxxxxxx-1-xxxxxxxxxxx |
|
|
Xxxxxxxx, xxxxxxxxxxx X |
xxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxx, xxxxxxxxxxx X |
xxxxxxxx 4-fenyl-1-methylpiperidin-4-karboxylová |
|
|
Piminodin |
ethyl-1-(3-anilinopropyl)-4-fenylpiperidin-4-karboxylát |
|
|
Piritramid |
1'-(3,3-difenyl-3-kyanpropyl-4'-ureido-1,4'-bipiperidin |
|
|
Proheptazin |
4-fenyl-1,3-dimethylazepan-4-yl-propanoát |
|
|
Properidin |
isopropyI-4-fenol-1-methylpiperidin-4-karboxylát |
|
|
Racemethorfan |
(9RS,13RS,14RS)-3-methoxy-17-methylmorfinan |
|
|
Racernoramid |
(3RS)-2,2-dyfenil-3-methyl-4-morfolino-1-(pyrrolidin-1-yl)butan-1-on |
|
|
Racemorfan |
(9RS,13RS,14RS)-17-methylmorfinan-3-ol |
|
|
Rernifentanil |
methyl-3-[4-(N-acetonylanilono)4-(methoxykarbonyl)]piperidino]propanoát |
|
|
Sufentanil |
N-{4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]piperidin-4-yl}propananilid |
|
|
Tapentadol |
3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]fenol |
|
|
Thebain |
4,5α-epoxy-3,6-dimethoxy-17-triethylmorfina-6,8-dien |
|
|
Thebakon |
(5R)-4,5-epoxy-3-methoxy-17-methyImorfin-6-en-6-yl-acetát |
|
|
Thiofentanyl |
N-{1-[2-(2-thienyl)ethyl]piperidin-4-yl}propananilid |
|
|
Tilidin |
ethyl-(1RS,2RS)-2-(dimethylamono)-1-fenylcyklohex-3-en-1-karboxylát |
|
|
Trimeperidin |
(RS)-4-fenyl-4-(1,2,5-trimethylpiperidin-4-yl)propanoát |
Včetně xxxxxxx xxxxxxxx látek xxxxxxxxx v xxxxx xxxxxxx, xxxx estery x ethery xxxxxxxx xxxxx xxxxxxxxx x xxxxx seznamu x xxxx xxxxxxxx látek xxxxxxxxx x tomto xxxxxxx včetně solí xxxxxxx, xxxxxx x xxxxx xx xxxxx xxxxxxxxx, xxx xxxx xxxx xxxxx xxxxxxxxx.
Xxxxxxx č. 2 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 2 xxxxxxxx xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx název (XXX) v xxxxxx xxxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxx |
|
|
Xxxxxxxxxxxxxxxx |
(1X,2X)-1-xxxxxx-3-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxx-xxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx |
|
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxx |
4,5α-xxxxx-17-xxxxxx-3-(2-xxxxxxxxxxxxxxx)xxxxxx-7-xx-6α-xx |
|
|
Xxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxxxxx |
|
|
Xxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx--7-xx-6-xx-xxxxxxxxx |
|
|
Xxxxxxxxx |
4,5α-xxxxx-3-xxxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxx |
X-[(1XX)-1-xxxxxx-2-xxxxxxxxxxxxxxx]-X-(2-xxxxxxx)xxxxxxxxxx |
Xxxxxx izomerů xxxxxxxx xxxxx xxxxxxxxx v xxxxx seznamu, xxxx xxxx xxxxxxxx látek xxxxxxxxx x tomto xxxxxxx, xxxxxx xxxx xxxxxxx xxxxx xxxxxxxxx x tomto seznamu xx xxxxx xxxxxxxxx, xxx xxxx soli xxxxx xxxxxxxxx.
Příloha x. 3 x nařízení xxxxx x. 463/2013 Sb.
Seznam x. 3 omamných xxxxx
|
Xxxxxxxxxxx nechráněný xxxxx (XXX) x českém xxxxxx |
Xxxxxxxx název xxxxx XXXXX |
Xxxxxxxx |
| Xxxxxxxxxxxxxx | X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxx | |
| Xxxxxxxxxxxxxxxx | X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxx-2-xxxxxx | |
|
Xxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxx |
[5X,6X,7X,14X)-4,5-xxxxx-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx- 17-xxxxxx-6,14-xxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxx |
(5X,6X)-4,5-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6-xxxx-xxxxxxxx |
|
|
Xxxxxxxxxxx |
1-[4-(3-xxxxxxxxxxxx)-1-xxxxxxxxxxxxxxx-4-xx]xxxxxx-1-xx |
|
|
Xxxxxx |
X xxxxxxxx xxxxxx pro xxxxxxx xxxxxxx uvedené x xxxxxxx x. 1 |
|
|
Xxxxxxxxxx x xxxxxx |
Xxxxxx xxxx xxxxxxxx xxxxx xxxxxxxxx x xxxx xxxxxxx xx xxxxx xxxxxxxxx, xxx xxxx xxxx xxxxx xxxxxxxxx.
Příloha x. 4 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 4 xxxxxxxxxxxxxx xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) v xxxxxx xxxxxx / xxxxxx xxxxx |
Xxxxx mezinárodní xxxxxxxxxx xxxxx xxxx xxxxx xxxxxx xxxxx |
Xxxxxxxx xxxxx xxxxx IUPAC |
Poznámka |
|
AB-CHMINACA |
N-[(1S)-1-(aminokarbonyl)-2-methylpropyl]-1(cyklohexylmethyl)-1H-indazol-3-karboxamid |
||
|
AB-FUBINACA |
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorbenzyl)-1H-indazol-3-karboxamid |
||
|
ADB-CHMINACA |
N-[1-(aminokarbonyl)-2,2-dimethylpropyl]-1-(cyklohexylmethyl)-1H-indazol-3-karboxamid |
||
|
ADB-FUBINACA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-[(4-fluorfenyl)methyl] indazol-3-karboxamid |
||
|
ADB-PINACA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazol-3-karboxamid |
||
|
AH-7921 |
3,4-dichlor-N-{[1-(dimethylamino)cyklohexyl]methyl}benzamid |
||
|
AM-2201 |
[1-(5-fluorpentyl)-1H-indol-3-yl](naftalen-1-yl)methanon |
||
|
AMB-CHMICA |
methyl (2X)-2-{[1-(xxxxxxxxxxxxxxxx)xxxxx-3-xxxxxxxx]xxxxx}-3-xxxxxxxxxxxxxx |
||
|
5-Xxxxxxxxxxxxxxxx |
5-XXX |
5-(2-xxxxxxxxxxx)xxxxx |
|
|
XXXXXXX |
X-(xxxxxxxxx-1-xx)-1-xxxxxx-1X-xxxxxxx-3 -xxxxxxxxxx |
XXX48 |
|
|
xx-XXX |
2-xxxxx-1-(4-xxxxxxxxxxxx) xxxxxx-1-xx |
||
|
Xxxxxxxxx |
xx-XXXX |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
2-Xxxxxxxxxxxxxxxx |
2-XXX |
(XX)-1-(2-xxxxxxxxx)-2-xxxxxxxxxxxxxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxx |
3-XXX |
(XX)-1-(3 -xxxxxxxxx)-2-xxxxxxxxxxxxxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxx |
4-XXX |
(XX)-1-(4-xxxxxxxxx)-2-xxxxxxxxxxxxxxxxx-1-xx |
Xxxxxxxxx |
|
25X-XXXXx |
2-(4-xxxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx |
Xxxxx-36 |
|
|
25X-XXXXx |
2-(4-xxxxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx |
2X-X-XXXXx |
|
|
25X-XXXXx |
2-(4-xxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx |
XXXXx-2X-X |
|
|
Xxxxx-Xxxxxxxxx |
(2X)-1-(4-xxxxxxxx[2,3-x][1]xxxxxxxxxx-8-xx)xxxxxx-2-xxxx |
||
|
Xxxxxxx |
xx-XXXX |
2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx)]xxxxx-1-xx |
X1 |
|
2-Xxxxxxxxxxxxxx |
2-XX |
1-(2-xxxxxxxxxx)xxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxx |
3-XX |
1-(3-xxxxxxxxxx)xxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxx |
4-XX |
1-(4-xxxxxxxxxx)xxxxxx-2-xxxx |
XXX |
|
2X-X |
2-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxx-1-xxxx |
||
|
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
x-XXX |
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
Xxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxxxxxxx |
2X-X |
(4-xxx-2,5-xxxxxxxxxxxxxxxxx)xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-2 |
[4-(xxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-7 |
[4-(xxxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
|
XX-47,497 |
2-[(1X,3X)-3-xxxxxxxxxxxxxxxxx]-5-(2-xxxxxxxxxxx-2-xx)xxxxx |
||
|
XXX-13 |
(xxxxxxxx-1-xx)[4-(xxxxxxxxx)xxxxxxxx-1-xx]xxxxxxxx |
XX-13 |
|
|
XXXX |
1,4-xxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxx |
2-(xxxxxxxxxxx)-2-xxxxx-xxxxxxxxxxxx |
||
|
Xxxxxxxxxxxx-2-xxxxx xxxxxxxx |
X-(2-xxxxxxxxxx)-1-(2-xxxxxxxxxx)xxxxxxxxx-4-xxxx |
||
|
Xxxxxxxxxxxxxxxx |
XXX |
X,X-xxxxxxx-X-[2-(xxxxx-3-xx)xxxxx]xxxx |
|
|
Xxxxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
x-Xxxxxx-4-xxxxxxxxxxxxxx |
4,4'-XXXX |
4-xxxxxx-5-(4-xxxxxxxxxxx)-4,5-xxxxxxx-1,3-xxxxxx-2-xxxx |
x4-XXXX |
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
3-(1,2-xxxxxxxxxxxxxx)-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x] xxxxxxx-1-xx |
|
|
3,4-Xxxxxxxxxxxxxxxxxxx |
3,4-XXXX |
1-(3,4-xxxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxxxxxxxxxxx |
XXX |
X-[2-(xxxxx-3-xx)xxxxx]-X,X-xxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
XXX |
(2XX)-1-(4-xxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
2,5-Xxxxxxxxx-4-xxxxxxxxxxxxxx |
XXX |
1-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-1-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxx |
XXX, XXX |
(2XX)-1-(2,5-xxxxxxxxx-4-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
2,5-Xxxxxxxxx-4-xxxxxxxxxxxx |
XXX |
1-(4-xxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxx |
Xxxxxxx |
(2XX)-1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxxxxxx |
(XX)-xxxxx 2-fenyl-2-piperidin-2-ylacetát |
||
|
2-Ethylmethkathinon |
2-EMC |
(RS)-2-methylamino-1-(2-ethylfenyl)propane-1-on |
|
|
3 -Xxxxxxxxxxxxxxxxx |
3-XXX |
(XX)-2-xxxxxxxxxxx-1-(3-xxxxxxxxxx)xxxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
(XX)-2-xxxxxxxxxxx-1-(4-xxxxxxxxxx)xxxxxxx-1-xx |
|
|
Xxxxxxxxxx |
3-(2-xxxxxxxxxx)xxxxx |
||
|
2-Xxxxxxxxxxxxxx |
2-XX |
1-(2-xxxxxxxxxx)xxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxx |
3-XX |
1-(3-xxxxxxxxxx)xxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxx |
4-XX |
1-(4-xxxxxxxxxx)xxxxxx-2-xxxx |
|
|
5X-XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
|
5X-XXXXXXX |
5X-XXX48 |
X-(xxxxxxxxx-1-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
|
|
5X-XXX-XXXXXX |
5X-XXX |
Xxxxxx 2-({[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xx]xxxxxxxx}xxxxx)-3-xxxxxxxxxxxxxx |
5X-XXX |
|
Xxxxxxxx xxxxxxxxx analog |
N-fenyl-N-[1-(2-fenylethyl)-4-piperidinyl]-butanamid |
||
|
4-Fluor-butyrfentanyl |
4F-BF |
N-(4-fluorofenyl)-N-[(1-(2-fenylethyl)-4 xxxxxxxxxxx)]xxxxxxxxx |
|
|
4-Xxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
Xxxxxxxxx |
|
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
(XX)-1-(2-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxxxxx |
3-XXX |
(XX)-1-(3-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
(XX)-1-(4-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
5X-XXXX-XXXXXX |
xxxxxx (S)-2-({[1-(5-fluorpentyl)-1H-indazol-3-yl]karbonyl}amino)-3,3-dimethylbutanoát |
||
|
5FUR-144 |
[1-(5-fluorpentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyklopropyl)methanon |
XLR-11 |
|
|
Furanylfentanyl |
FU-F |
N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]-furan-2-karboxamid |
2-furanoylfentanyl |
|
Hydroxytenamfetamin |
(2RS)-N-hydroxy-1-[3,4-(methylendioxy)fenyl]propan-2-amin |
||
|
(iso)Butyryl-F-fentanyl X-xxxxxx xxxxxx |
X-(1-xxxxxxxxxxxxxxx-4-xx)-X-(4-xxxxxxxxxx)-xxxxxxxxx |
||
|
XXX-018 |
(xxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3 -yl)methanon |
||
|
JWH-073 |
(1-butyl-1H-indol-3-yl)(naftalen-1-yl)methanon |
||
|
JWH-081 |
(4-methoxynaftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon |
||
|
JWH-122 |
(4-methylnaftalen-1-yl)(1-pentyl- 1H-indol-3-yl)methanon |
||
|
JWH-200 |
[1-(2-morfolinoethyl)-1H-indol-3-yl] (xxxxxxxx-1-xx)xxxxxxxx |
||
|
XXX-250 |
2-(2-xxxxxxxxxxxx)-1-(1-xxxxxx-1X-xxxxx-3-xx)xxxxx-1-xx |
||
|
XXX-398 |
(4-xxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
Xxxxxxxx |
(2XX)-2-xxxxx-1-xxxxxxxxxxx-1-xx |
||
|
(+)-Xxxxxxxx |
XXX, XXX-25 |
(+)-8β-(3,3-xxxxxxxxxxxxxx)-6-xxxxxx-9,10-xxxxxxxxxxxxxxxx |
|
|
2-Xxxxxxxxxxxxxxx |
2-XX |
(2XX)-1-(2-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxx |
3-XX |
(2XX)-1-(3 -xxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxxx |
4-XX |
(2XX)-1-(4-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
XXXX |
1-xxxxxx-4-xxxxxxxxxxxxxxx |
||
|
x-Xxxxxxxxxxxxxxxxxxx |
xXXX |
1-(3-xxxxxxxxxx)xxxxxxxxx |
|
|
Xxxxxxxxxxxx |
XXX |
(2XX)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
XXXX |
5,6-(xxxxxxxxxxxxx)xxxxx-2-xxxx |
||
|
Xxxxxxxxxxxxxxxxx |
XXX, XXXX |
(2XX)-X-xxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
Xxxxxxx |
xx-XXXX |
2-xxxxxxxxxx-1-(3,4-xxxxxxxxxxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-X-xxxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
XXXX-XXXXXX |
X-[[1-(xxxxxxxxxxxxxxxx)-1X-xxxxx-3-xx]xxxxxxxx]-3-xxxxxx- xxxxxx, xxxxxx xxxxx |
||
|
XXXX-XXXXXXXX |
2-[[1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxx] xxxxx]-3,3- dimethyl-butanoát |
||
|
3,4-Methylendioxypyrovaleron |
MDPV |
1-[3,4-(methylendioxy)fenyl]-2-(pyrrolidin-1-yl)pentan-1-on |
MDPK |
|
2-Methylethkathinon |
2-MEC |
2-(ethylamino)-1-(2-methylfenyl)propan-1-on |
|
|
3-Methylethkathinon |
3-MEC |
2-(ethylamino)-1-(3-methylfenyl)propan-1-on |
|
|
4-Methylethkathinon |
4-MEC |
2-(ethylamino)-1-(4-methylfenyl)propan-1-on |
|
|
4-Methylmetkathinon |
Mefedron |
2-(methylamino)-1-(4-methylfenyl)propan-1-on |
|
|
5-MeO-AMT |
5-methoxy-α-methyltryptamin |
||
|
4-Methoxybutyr xxxxxxxx |
4-XxX-XX |
X-(4-xxxxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx] xxxxxxxxx |
|
|
5-XxX-XXXX |
X-[2-(5-xxxxxxx-1X-xxxxx-3-xx)xxxxx]-X-(xxxx-2-xx-1-xx)xxxx-2-xx-1-xxxx |
||
|
3-Xxxxxxxxxxxxxxxxxx |
3-XxX-XXX |
1-[1-(3-xxxxxxx fenyl)cyklohexyl]piperidin |
|
|
Meskalin |
3,4,5-trimethoxyfenethylamin |
||
|
Methoxetamin |
MXE |
2-(ethylamino)-2-(3-methoxyfenyl)cyklohexanon |
|
|
Methylaminorex |
(±)-5-fenyl-4-methyl-4,5-dihydrooxazol-2-amin |
||
|
Methylon |
Bk-MDMA |
2-(methylamino)-1-[3,4-(methylendioxy)fenyl]propan-1-on |
|
|
2-Methylmetamfetamin |
2-MMA |
1-(2-methylfenyl)-N-methylpropan-2-amin |
|
|
3-Methylmetamfetamin |
3-MMA |
1-(3-methylfenyl)-N-methylpropan-2-amin |
|
|
2-Methylmetkathinon |
2-MMC |
2-(methylamino)-1-(2-methylfenyl)propan-1-on |
|
|
3-Methylmetkathinon |
3-MMC |
2-(methylamino)-1-(3-methylfenyl)propan-1-on |
|
|
Methoxytenamfetamin |
MMDA |
(2RS)-1-[5-methoxy-3,4-(methylendioxy)fenyl]propan-2-amin |
|
|
Methylthienylpropamin |
MPA |
N-methyl-1-(thiofen-2-yl)propan-2-amin |
|
|
MT-45 |
1-cyklohexyl-4-(1,2-difenylethyl)-piperazin |
||
|
2-Methylthioamfetamin |
2-MTA |
(2RS)-1-[2-(methylsulfanyl)fenyl]propan-2-amin |
|
|
3-Methylthioamfetamin |
3-MTA |
(2RS)-1-[3-(methylsulfanyl)fenyl]propan-2-amin |
|
|
4-Methylthioamfetamin |
4-MTA |
(2RS)-1-[4-(methylsulfanyl)fenyl]propan-2-amin |
|
|
Naftylpyrovaleron |
Nafyron |
1-(naftalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-on |
O-2482 |
|
OC xxxxxxxx |
X-3217 |
X-(2-xxxxxxxxxx)-2-xxxxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
|
X-Xxxxxxxxxxxxxxxxx |
XXX |
3-{-2-[(xxxxxxxxxxxxx)xxxxxx]-1-xxxxxxxxxxxxxxxxx} xxxxx |
|
|
Xxxxxxxxx |
3-xxxxx-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x]xxxxxxx-1-xx |
||
|
Xxxxxxxxxxx |
XXX |
X-xxxxx-1-xxxxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxx |
xxxxxxxxx |
1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
x-Xxxxxxxxxxxxxxxxxxx |
xXXX |
1-(4-xxxxxxxxxx)xxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(4-xxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXXX |
1-(4-xxxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
Xxxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx-xxxxxxxxxx-xxxxxx |
||
|
Xxxxxxxx |
Xxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx |
|
|
α-XXX |
2-(xxxxxxxxxx-1-xx)-1-(xxxxxxx-2-xx)xxxxxx-1-xx |
||
|
Xxxxxxxxxxxx |
XXX, PCPY |
1-(1-fenylcyklohexyl)pyrrolidin |
|
|
α -PVP |
1-fenyl-2-(pyrrolidin-1-yl)-1-pentan-1-on |
||
|
Salvinorin X |
Xxxxxxxxxx X |
xxxxxx-(2XX,4xX,6xX,7X,9XX,10xXX,10xX)-9-xxxxxxx-2-(xxxxx-3-xx)-6x,10x-xxxxxxxx-4,10-xxxxxxxxxxxxxxxx-1X-xxxxx[x]xxxxxxxxxx-7-xxxxxxxxxx |
|
|
Xxxxxxxxxxxx |
XXX |
1-[1-(2-xxxxxxx)xxxxxxxxxx]xxxxxxxxx |
|
|
1-(3-Xxxxxxxxxxxxxxxxxxx)xxxxxxxxx |
XXXXX |
1-[3-(xxxxxxxxxxxxxx)xxxxx]xxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXX |
X6x(10x)-, D6a(7)-, X7-, D8-, D10-, X9(11)-xxxxxxxxxxxxxxxxxxxx a jejich xxxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(3,4,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxx-2 |
XXX-2 |
(2XX)-1-(2,4,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
XX-144 |
(1-xxxxxx-1X-xxxxx-3-xx)-(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
XXXX-018 |
|
|
X-47700 |
3,4-xxxxxxx-X-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
|
X-15 |
4-xxxxx-X-(1-xxxxxxxxxxxxxxxxx-2-xxxxxx)xxxxxxxxxxxxxxxx |
||
|
X-18 |
4-xxxxx-X-(1-[2-(4-xxxxxxxxxx)xxxxx]-xxxxxxxxx-2-xxxxxx)xxxxxxxxxxxxxxxx |
Xxxxxx stereoizomerů xxxxxxxxxxxxxx xxxxx, až xx xxxxxxxx xxxxxxx, uvedených x tomto xxxxxxx xx všech xxxxxxxxx, xxx xxxx xxxxxxxxxxxxx xxxxx xxxxxxxxx xxxxx xxxxxxxxxx xxxxxxxxxx označení x solí psychotropních xxxxx uvedených x xxxxx xxxxxxx xx xxxxx případech, xxx xxxxx xxxxxxxxx.
Xxxxxxx x. 5 x xxxxxxxx vlády x. 463/2013 Sb.
Seznam x. 5 xxxxxxxxxxxxxx xxxxx
|
Xxxxxxxxxxx nechráněný název (XXX) v xxxxxx xxxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx xxxx xxxxxx xxxxx |
Xxxxxxxx název xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxx |
(2XX)-1-xxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxx |
xxxxxxxx 7-[(10,11-xxxxxxx-5X-xxxxxxx[x,x][7]xxxxxxx-5-xx) xxxxx]xxxxxxxxx |
||
|
Xxxxxxxxxx |
(2X)-2-[(5X,6X,7X,14X)-17-(xxxxxxxxxxxxxxxxx)-4,5α-xxxxx-3- xxxxxxx-6-xxxxxxx-6α,14-xxxxxxxxxxxxxx-7x-xx]-3,3-xxxxxxxx xxxxx-2-xx |
||
|
Xxxxxxxxxxxxxxxxxxxxx xxxx |
2X-X |
(4-xxxx-2,5-xxxxxxxxxxxxxxxxx)xxxx |
|
|
Xxxxxxxxxxxx |
(2X)-1-xxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxxx |
XXX |
1-(1-xxxxxxxxxxxxxxx)xxxxxxxxx |
|
|
Xxxxxxxxx |
7-(2-{[(2XX)-1-xxxxxxxxxxx-2-xx]xxxxx}xxxxx)-1,3-xxxxxxxx-7X- xxxxx-2,6-xxxx |
||
|
Xxxxxxxxxxx |
2-xxxxX-3-xxxxxxxxxxxxxx |
||
| Xxxxxxxxx | 1-xxxxx-2-xxxxxxxxx-xxx-2-xxxx | ||
|
Xxxxxxxxxxxxx |
5-(2-xxxxxxxxxx)-1-xxxxxx-7-xxxxx-1X-1,4-xxxxxxxxxxxxx-2(3X)-xx |
||
|
XXX |
xxxxxxxx 4-hydroxybutanová |
||
|
Levamfetamin |
(2RS)-1-fenylpropan-2-amin |
||
|
Levmetamfetamin |
(2RS)-1-fenyl-N-methylpropan-2-amin |
||
| Lisdexamfetamin | (2S)-2,6-diamino-N-[(2S)-1-fenylpropan-2-yl]hexanamid | ||
|
Meklochalon |
3-(2-chlorfenyl)-2-methyl-1,2-dihydrochinazolin-4(3H)-on |
||
|
Metachalon |
2-rnethyl-3-(2-methylfenyl)-1,2-dihydrochinazolin-4(3H)-on |
||
|
Metamfetamin |
(2S)-1-fenyl-N-methylpropan-2-amin |
||
|
Metamfetamin racemický |
(2RS)-1-fenyl-N-methylpropan-2-amin |
||
|
Methylfenidát |
methyl-(2RS)-2-fenyl-2-[(2RS)-piperidin-2-yl]acetát |
||
|
Sekobarbital |
kyselina 5-xxxxx-5-(1-xxxxxxxxxxx)xxxxxxxxxxx |
||
|
Xxxxxxxxxx |
xxxxx-9-XXX |
Δ9-xxxxxxxxxxxxxxxxxxx (XXX) x xxxx xxxxxxxxxxxxx |
xxxx. (-)-xxxxx-Δ9-XXX |
|
Xxxxxxxx |
(2XX)-1-xxxxx-1-xxxxxxx-3-[4-(2-xxxxxxxxxxxxxxx)xxxxxxxxx-1-xx] xxxxxx-2xx |
Xxxxxx xxxx látek xxxxxxxxx v xxxx xxxxxxx xx xxxxx xxxxxxxxx, xxx xxxxxxxxx xxxxxxxx xxxx xx xxxxx.
Příloha x. 6 x xxxxxxxx xxxxx x. 463/2013 Sb.
Seznam x. 6 xxxxxxxxxxxxxx xxxxx
|
Xxxxxxxxxxx nechráněný xxxxx (XXX) x xxxxxx xxxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx nebo xxxxxx xxxxx |
Xxxxxxxx xxxxx podle XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxx |
xxxxxxxx 5-xxxxx-5-xxxxxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxx |
xxxxxxxx 5-allyl-5-isobutylbarbiturová |
||
|
Cyklobarbital |
kyselina 5-(1-xxxxxxxx-1-xx-1-xx)-5-xxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxx |
(3XX)-3-xxxxx-3-xxxxxxxxxxxxxx-2,6-xxxx |
||
|
Xxxxxx |
(+)-xxxxxxxxxxxxxxxx |
(1X,2X)-2-xxxxx-1-xxxxxxxxxxx-1-xx |
|
|
Xxxxxxxxxxx |
(2X,6X,11X)-6,11-xxxxxxxx-3-(3-xxxxxxxxx-2-xx-1-xx)-1,2,3,4,5,6- xxxxxxxxx-2,6-xxxxxxx-3-xxxxxxxxxx-8-xx |
||
|
Xxxxxxxxxxxxx |
xxxxxxxx 5-xxxxx-5[(1XX)-1-xxxxxxxxxxx]xxxxxxxxxxx |
Xxxxxx xxxx xxxxx xxxxxxxxx x xxxx xxxxxxx xx xxxxx xxxxxxxxx, xxx existence xxxxxxxx xxxx xx xxxxx.
Xxxxxxx x. 7 x xxxxxxxx vlády x. 463/2013 Sb.
Seznam x. 7 xxxxxxxxxxxxxx xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx název (XXX) v českém xxxxxx |
Xxxxx mezinárodní nechráněný xxxxx nebo xxxxxx xxxxx |
Xxxxxxxx xxxxx podle XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxxx |
5,5-xxxxxxxxxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxx |
8-xxxxx-6-xxxxx-1-xxxxxx-4X.[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
|
Xxxxxxxxxx |
2-(xxxxxxxxxxxx)-1-xxxxxxxxxxx-1-xx |
||
|
Xxxxxxxx |
5-xxxxx-4,5-xxxxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxx |
5,5-xxxxxxxxxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxxx |
(+)-X-xxxxxx-X-(2-xxxxx-1-xxxxxxxxxxx)-X-xxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxx |
1-xxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxx |
7-xxxx-5.(2-xxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
2-xxxx-4-(2-xxxxxxxxxx)-9-xxxxxx-6X-xxxxxx[3,2-x][1,2,4]xxxxxxxx[4,3-x]xxxxxxxx |
||
|
Xxxxxxxxxxxx |
5-xxxxx-5-xxxxxxxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxx-2xx |
||
|
Xxxxxxxxx |
8-xxxxx-6-xxxxx-4X-[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
|
Xxxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
|
Xxxxxxxxxxxxx |
1-xxxxx-3-xxxxxxxxx-1-xx-4-xx-3-xx |
||
|
Xxxxxxxxxxxxxx |
(±)-2-(xxxxxxxxxx)-1-xxxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxx |
xxxxx-7-xxxxx-5-(2-xxxxxxxxxx)-2-xxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3- karboxylát |
||
| Fenazepam | 7-bromo-5-(2-chlorofenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
|
Fendimetrazin |
(2S,3S)-2-fenyl-3,4-dimethylmorfolin |
||
|
Fenkamfamin |
(±)-2-(ethylamino)-3-fenylbicyklo[2.2.1]heptan |
||
|
Fenobarbrial |
5-ethyl-5-fenylbarbiturová kyselina |
||
|
Fenproprex |
(±)-1-fenyl-2-[(2-kyanethyl)amino]propan |
||
|
FIudiazepam |
7-chlor-5-(2-fluorfenyl)-1-methyl-1,3-dihydro-2G-1,4-benzodiazepin-2-on |
||
|
FIurrazepam |
7-chlor-2-[2-(diethylamino)ethyl]-5-(2-fluorfenyl)-1,3-dihydro-2H-1,4-bezodiazepin- 2-xx |
||
|
Xxxxxxxxx |
7-xxxxx-5-xxxxx-1-(2,2,2-xxxxxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxxx |
10-xxxx-11x-(2-xxxxxxxxxx)-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4]xxxxxxxxxxxxx -6(5X)-xx |
||
|
Xxxxxxxxxxxxxxxx |
7-xxxxx-5-xxxxx-2-(xxxxxxxxxxx)-3X-1,4-xxxxxxxxxxxxx-4-xxxx |
||
|
Xxxxxxxxx |
7-xxXxx-5-xxxxx-1-xxxxxx-2-xxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-3-xx-xxxxxxxx xxxxxxxx |
||
|
Xxxxxxx |
(2XX)-2-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxxxxxx-1-xx |
||
|
Xxxxxxxxx |
11-xxxxx-12x-xxxxx-2,8-xxxxxxxx-8,12x-xxxxxxx-4X-[1,3]xxxxxxx[3,2-x][1,4] xxxxxxxxxxxx-4,7(6X)-xxxx |
||
|
Xxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-1X-1,5-xxxxxxxxxxxx-2,4(3X,5X]-xxxx |
||
|
Xxxxxxxxxx |
5-{2-xxxxxxxxxX}-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
7-xxxxx-5-xxxxx-2-xxx--2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3-xxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxxx |
5-(2-xxxxxxxxxx)-7-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-xxxxxx[2,3-x][1,4]xxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
10-xxxxx-11x-(2-xxxxxxxxxx)-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4] xxxxxxxxxxxxx-6(5X)-xx |
||
|
Xxxxxxxxx |
XXX |
(-)-1-(xxxxxxxxxxxxx)-1,2-xxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
3-(2-xxxxxxxxxx)-2-[(4-xxxxxxxxxxxxxxx-1-xx)xxxxxx]-8-xxxxx-2,4-xxxxxxx-1X- xxxxxxxx[1,2-x][1,4]xxxxxxxxxxxxx-1-xx |
||
|
Xxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2 -on |
||
|
Mazindol |
5-(4-chlorfenyl)-2,5-dihydro-3H-imidazo[2,1-α]-isoindol-5-ol |
||
|
Medazepam |
7-chlor-5-fenyl-1-methyl-2,3-dihydro-1H-1,4-benzodiazepin |
||
|
Mefenorex |
(±)-2-[(3-chlorpropyl)amino]-1-fenylpropan |
||
|
Meprobamát |
2-methyl-2-propylpropan-1,3-diyl-dikarbamát |
||
|
Mesokarb |
N-(fenylkarbamoyl)-3-(2-fenyl-1-methylethyl)sydnonimin |
||
|
Methylfenobarbital |
5-ethyl-5-fenyl-1-methylbarbiturová kyselina |
||
|
Methyprylon |
3,3-diethyl-5-methylpiperidin-2,4-dion |
||
|
Midazolam |
8-chlor-6-(2-fluorfenyl)-1-methyl-4H-imidazol[1,5-α][1,4]bezodiazepin |
||
|
Nimetazepam |
5-fenyI-1-methyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Nitrazepam |
5-fenyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Nordazepam |
7-chlor-5-fenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Oxazepalll |
7-chlor-5-fenyl-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Oxazalant |
10-chlor-11b-fenyl-2-methyl-2,3,7,11b-tetrahydroozazolo[3,2-d][1,4] xxxxxxxxxxxxx-6(5X)-xx |
||
|
Xxxxxxx |
5-xxxxX-2-xxxxx-1,3 -oxazolidin-4-on |
||
|
Pinazepam |
7-cchlor-4-fenyl-1-(prop-2-yl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Pipradrol |
difenyI(2-piperidyl)methanol |
||
|
Prazepam |
7-chlor-1-(cyklopropylmethyl)-5-fenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Pyrovaleron |
(±)-1-(4-methylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on |
||
|
Sekbutabarbital |
5-ethyl-5-(1-rnethylpropropyl)barbiturová kyselina |
||
|
Temazepam |
(RS)-7-chlor-5-fenyl-3-hydroxy-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Tetrazepam |
7-chlor-5-(cyklohex-1-en-1-yl)-1-methyl-1,3-dihydro-2H-1,4-bezodiazepin-2-on |
||
|
Triazolamn |
8-chlor-6-(2-chlorfenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-α][1,4]benzodiazepin |
||
|
Vinylbital |
5-(1-methylbutyl)-5-vinylbarbiturová xxxxxxxx |
||
|
Xxxxxxxx |
X,X,6-xxxxxxxxx-2-(4-xxxxxxxxxxx)xxxxxxxx[1,2-α]xxxxxxx-3-xxxxxxxx |
Xxxxxx solí látek xxxxxxxxx v xxxx xxxxxxx xx xxxxx xxxxxxxxx, xxx xxxxxxxxx xxxxxxxx xxxx xx xxxxx.
Xxxxxxx x. 8 x nařízení xxxxx x. 463/2013 Sb.
Seznam x. 8 xxxxxxxxx xxxxxxxxx
|
Xxxxxxxxx obsahující: |
Podmínky: |
||
|
1) |
jednu x xxxxxxxx xxxxx: xxxxxxxxxxxxxxxxxxx xxxxxxxxxxxxx xxxxXxxxxxx xxxxxxxx xxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxxx |
Xxxxx xxxxxxxxx xxxxx xxxx více xxxxxxx xxxxx (xxxxxxx xxxx omamných) x xxxxxxxx xxxxxx xxxxx |
|
|
x) |
x xxxxx xxxxxxx, xxxxxxx, xxxxxx, čípku, xxxx. x xxxx xxxxxx xxxxx xxxxx xxxxxxxxxx 100 xx, |
||
|
x) |
x roztoku xxxxx být xxxxxxxxxxx xxxxx než 2,5 % |
||
|
2) |
xxxxxxxxx |
x) |
Xxxxxxxx xxxxxxxxxx xxxxx xxxxxxxxxx x xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. x xxxx xxxxxx xxxxx 0,5 xx. |
|
x) |
Xxxxxxxx xxxxxxx-xxxxxxx xxxx xxx xxxxxxx 5 % k xxxxxxxx xxxxxxxxxxxx v xxxxx xxxxxxx, kapsli, xxxxxx, xxxxx, popř. xxxx lékové formě. |
||
|
3) |
difenoxylát |
a) |
Množství xxxxxxxxxxxx xxxxx xxxxxxxxxx x xxxxx xxxxxxx, xxxxxxx, ampuli, xxxxx, xxxx. x xxxx xxxxxx xxxxx 2,5 xx. |
|
x) |
Xxxxxxxx atropin-sulfátu xxxx xxx xxxxxxx 1 % k xxxxxxxx xxxxxxxxxxxx x xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, popř. x xxxx xxxxxx xxxxx. |
||
|
4) |
xxxxxxxxxxxxxxxx |
Xxxxxxxx xxxxxxxxxxxxxxxxx |
|
|
x) |
xxxxx xxxxxxxxxx 135 xx x jedné xxxxxxx, tobolce, xxxxxx, xxxxx, xxxx. x xxxx lékové xxxxx. |
||
|
x) |
x xxxxxxx xxxxx být xxxxxxxxxxx vyšší než 2,5 %. |
||
|
Přípravek xxxxx xxxxxxxxx xxxxxx xxxxxxxxxxxx xxxxx. |
|||
|
5) |
xxxxxx |
Xxxxxxxx xxxxxxx xxxxx xxxxxxxxxx 0,1 % xxxxxxx. |
|
|
6) |
xxxxx xxxx xxxxxx |
x) |
Xxxxxxxx xxxxxxx xxxxx xxxxxxxxxx 0,2 %. |
|
b) |
Dále xxxxx xxxxxxxxx xxxxx xxxx xxxx xxxxxxx xxxxx (xxxxxxx xxxx xxxxxxxx). |
||
|
Xxxxxx xxxxx x přípravku xxxxxxxx xxxxx xxx xxxxxx xxxxxxx xxxx x takovém xxxxxxxx, xxx ohrozila xxxxxxx xxxxxx |
|||
|
7) |
xxxxxxxxxxxxx xxxxxx s xxxxx |
x) |
Xxxxxxxx xxxx v xxxxxx xxxxx být xxxxx xxx 10 %. |
|
x) |
Xxxxxxxx ipekakuanhového xxxxxx xxxxx xxx xxxxx xxx 10 %. |
||
|
c} |
Množství xxxxx nebo více xxxxxxx xxxxx (nikoliv xxxx xxxxxxxxx) xxxxx xxx xxxxx než 80%. |
||
|
8) |
xxxxxxxxx |
x) |
Xxxxxxxxx xxxxxxxxx nesmí xxxxxxxxxx 100 xx x xxxxx xxxxxxx, xxxxxxx, ampuli, xxxxx, xxxx. x jiné Xxxxxx xxxxx. |
|
x) |
Xxxxxxxxx methylcelulosy x xxxxxxxxx musí xxx nejméně xxxxxx xxxx vyšší xxx xxxxxxxxx. |
||
Xxxxxx xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxx, xxxxxxx stupeň xxxxxx xx xxxxx xxx X4 nebo XX2.
Čl. XX
Xxxx nařízení xxxx xxxxxxxx x xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx a Xxxx (XX) 2015/1535 xx dne 9. xxxx 2015 x xxxxxxx xxx poskytování xxxxxxxxx v xxxxxxx xxxxxxxxxxx xxxxxxxx x xxxxxxxx xxx služby xxxxxxxxxx xxxxxxxxxxx.
Xx. II xxxxxx xxxxxxx xxxxxxxxx x. 46/2017 Sb. x xxxxxxxxx od 1.3.2017
Xxxxxx předpis x. 463/2013 Xx. xxxxx xxxxxxxxx dnem 1.1.2014.
Xx xxxxx tohoto xxxxxxxx xxxxxxxx xxxx xxxxxxxxxx xxxxx a xxxxxxxx xxxxxxxxxxx xxxxxxx xxxxxxxxx x.:
243/2015 Xx., kterým xx mění xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx
x xxxxxxxxx xx 1.10.2015
46/2017 Xx., xxxxxx xx xxxx xxxxxxxx vlády x. 463/2013 Xx., x xxxxxxxxx návykových xxxxx, xx xxxxx xxxxxxxx xxxxx č. 243/2015 Xx.
x xxxxxxxxx od 1.3.2017 x xxxxxxxx xxxxxxxxx xxxxxxxxxx, která xxxxxxxx xxxxxxxxx 1.5.2017
30/2018 Xx., kterým se xxxx xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx předpisů
s účinností xx 8.3.2018
242/2018 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx návykových xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x účinností od 25.10.2018
184/2021 Sb., xxxxxx xx xxxx xxxxxxxx xxxxx č. 463/2013 Xx., x seznamech xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx předpisů
s xxxxxxxxx od 3.6.2021
159/2022 Xx., kterým xx xxxx nařízení xxxxx x. 463/2013 Sb., x xxxxxxxxx návykových xxxxx, xx xxxxx xxxxxxxxxx předpisů
s xxxxxxxxx xx 1.7.2022
228/2023 Xx., xxxxxx se mění xxxxxxxx vlády č. 463/2013 Xx., x xxxxxxxxx návykových xxxxx, xx znění xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 1.8.2023
52/2024 Sb., xxxxxx xx mění nařízení xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx látek, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 6.3.2024 x 1.1.2025
176/2023 Sb., xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Sb., x xxxxxxxxx xxxxxxxxxx látek, xx xxxxx pozdějších xxxxxxxx
x účinností xx 1.7.2024 x 1.1.2025
419/2024 Xx., kterým xx xxxx nařízení xxxxx x. 463/2013 Sb., x xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x účinností xx 1.1.2025 x 1.4.2025
Xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx jiných xxxxxxxx xxxxxxxx v xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.
1) Xxxxxxxx xxxxxx x omamných látkách, xxxxxxxxx pod č. 47/1965 Sb., xx xxxxx Xxxxxxxxx x xxxxxxx Jednotné xxxxxx o xxxxxxxx xxxxxxx, xxxxxxxxxxx xxx č. 458/1991 Sb.
2) Úmluva x xxxxxxxxxxxxxx xxxxxxx, vyhlášená xxx č. 62/1989 Sb.